Why Did the Mounjaro Price Go Up in the UK?

The decision in front of you: pay the new price, wait, or find out whether you qualify for NHS treatment

Most people searching for why the Mounjaro price went up are really asking a more practical question: is the current cost still worth it, and what are my options? That framing is worth sitting with for a moment, because the answer depends on factors that are genuinely different for each person.

Eli Lilly's September 2025 list-price increase was substantial, and if you want the full picture of why Mounjaro has gone up in price, the factors behind that decision are worth understanding before you compare providers. Before it, the highest-strength pen retailed privately at roughly £122. After it, prices for that same dose typically sit between £200 and £375 depending on provider, with lower doses priced proportionally less. These figures are widely reported and hedged here because private providers set their own margins on top of the Lilly list price, so exact costs vary. You can explore what treatment involves through our Mounjaro overview, which covers the medicine's licensed use and how private access works.

The alternative route is the NHS. NICE recommended tirzepatide for NHS use in December 2024 (TA1026), and NHS England began phased rollout in June 2025, currently for adults with a BMI of 40 or above and four or more qualifying conditions. Eligibility is narrow and expanding gradually. If you don't meet those thresholds now, or if the waiting time in your area is long, a private prescription may still be the practical path. Our weight management overview sets out both routes side by side so you can weigh them up honestly.

The third option (doing nothing) is also a real choice, and not one anyone should feel rushed into. What matters is that the decision is yours, made with accurate information and, where treatment is right for you, proper clinical oversight.

What headline private prices do and don't include, and why the gap matters

When the price of Mounjaro went up, many providers responded by advertising lower headline figures that don't reflect the true cost of treatment. A quoted price per pen often excludes the consultation fee (sometimes £30–£80 at other services), the prescription fee, delivery charges, and any follow-up clinical support if you have questions mid-treatment.

A question our prescribers hear fairly often is: "I found it cheaper elsewhere, why is there such a difference?" The honest answer is that the components bundled into the price vary enormously. Some services charge per interaction; others include ongoing aftercare in a monthly subscription that auto-renews unless you cancel. Our breakdown of Mounjaro pricing walks through what to look for when comparing costs so you're comparing like with like.

At nume, one price covers the consultation, the prescription, the medicine itself and free next-working-day delivery. There are no subscriptions and no hidden fees. Every repeat order is reviewed clinically before it's approved, a named prescriber reads your case, not automated software. We're not the cheapest option on the market, and that's a deliberate choice: the components that add cost are the ones we consider non-negotiable.

If you'd like to understand more about how our clinical team approaches these decisions, our clinical lead's profile gives a sense of the standard we work to.

Why 'cheapest' is the wrong question for a prescription medicine

For a Prescription-Only Medicine like Mounjaro, price is not a neutral variable. The MHRA has issued repeated warnings about counterfeit weight-loss pens sold through social media and unofficial online channels. In October 2025, enforcement teams raided the first illicit UK manufacturing site producing fake tirzepatide pens. Some fake pens have contained insulin instead of tirzepatide, a potentially life-threatening substitution. The agency's Yellow Card scheme allows anyone to report a suspect seller, and that remains one of the most useful tools available to patients.

The legitimate supply chain runs through licensed UK pharmacies you can verify on the GPhC register. Our pharmacy's registration number is 9012878, you can confirm it directly at the GPhC pharmacy register. Medicines sourced through nume's pharmacy come from Eli Lilly's authorised UK distribution network; the provenance of what arrives in your fridge door is not in question.

The MHRA's public guidance on GLP-1 medicines is clear: these are not assessed for quick or cosmetic weight loss, and the clinical assessment a prescriber carries out before issuing a prescription exists for good reason. A saving of £20 or £30 per pen is not a meaningful benefit if the medicine is counterfeit, incorrectly stored, or dispensed without any clinical check on whether it's safe for you specifically. If you're trying to understand why Mounjaro is going up in price and whether further increases are likely, it's also worth reading about whether Mounjaro will go up in price again so you can plan ahead, but how to respond to the Mounjaro price rise practically is a separate question from buying safely, and cost should never lead that decision.

If you have questions before starting or want to understand the process, our FAQs cover the most common ones, and you can always reach the team through our contact page.